These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32015310)

  • 21. Intravitreal aflibercept for diabetic macular edema.
    Korobelnik JF; Do DV; Schmidt-Erfurth U; Boyer DS; Holz FG; Heier JS; Midena E; Kaiser PK; Terasaki H; Marcus DM; Nguyen QD; Jaffe GJ; Slakter JS; Simader C; Soo Y; Schmelter T; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Zeitz O; Metzig C; Brown DM
    Ophthalmology; 2014 Nov; 121(11):2247-54. PubMed ID: 25012934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
    Zacks DN; Johnson MW
    Retina; 2005; 25(2):135-40. PubMed ID: 15689801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurodegenerative biomarkers of the response to diabetic macular edema treatment].
    Petrachkov DV; Budzinskaya MV; Pavlov VG; Durzhinskaya MH; Khalatyan AS
    Vestn Oftalmol; 2020; 136(4. Vyp. 2):201-206. PubMed ID: 32880140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of diffuse diabetic macular edema treatment in relation to structural changes in macular region].
    Fursova AZ; Chubar NV; Tarasov MS; Sayfullina IF; Pustovaya GG
    Vestn Oftalmol; 2016; 132(4):35-42. PubMed ID: 27600893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.
    Shimura M; Yasuda K; Nakazawa T; Hirano Y; Sakamoto T; Ogura Y; Shiono T
    Retina; 2011 Apr; 31(4):748-54. PubMed ID: 21836404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    ; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD
    Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M; Yamashita M; Ogata N
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic Macular Edema: Traditional and Novel Treatment.
    Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
    Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diabetic macular edema on peripapillary retinal nerve fiber layer thickness profiles.
    Hwang DJ; Lee EJ; Lee SY; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4213-9. PubMed ID: 24833740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment.
    Wu PC; Lai CH; Chen CL; Kuo CN
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):59-64. PubMed ID: 21992557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
    Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
    J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.